During the procedure, surgeons observed significant enlargement of the prostate and bladder changes associated with long-term ...

A 77-year-old man suffering from a severely enlarged prostate was treated using an advanced minimally invasive laser ...

The Expander-2 trial randomly assigned men with BPH symptoms at 23 sites in the US and Canada to receive a temporary nitinol urethral implant, Urocross Expander, or a sham procedure.

Many people assume that bladder control problems are just a minor issue or a normal part of ageing, and therefore choose to ...

the hospital, the patient had been suffering from prolonged difficulty in urination along with repeated episodes of urinary retention, which had considerably impacted his quality of life ...

Corvention, a structural heart medical device company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its KardiaPSItm Balloon Catheter. The ...

Study showed immediate improvement in symptoms after intentional retrieval of device at 6 ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company focused on transforming the treatment of urothelial and specialty cancers, today announced UGN-103 achieved a 94.5% (95% CI: 86.1, 97.9) ...

Data Supported the FDA Approval of the Zenflow Spring® Implant and Delivery System for BPHAdditional presented data highlights patient ...

The coprimary efficacy endpoints were the proportion of patients with a 30% or greater improvement in IPSS from baseline to 3 months and the mean IPSS change from baseline to 12 months. The co-primary ...

Probability of Remaining Event-Free at Three Years by Kaplan-Meier Analysis After Achieving Complete Response at Three Months; First and Only FDA-Approved Medicine for Recur ...